We are live on !
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
Turnover
55.09%
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter Est. Return
+35.34%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$6.7M
(-3%)
Cap. Flow
-$47.5M
Cap. Flow % of AUM
Cap. Flow %
-22.27%
Top 10 Holdings %
Top 10 Hldgs %
8.05%
Holding
403
New
118
Increased
30
Reduced
151
Closed
104
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lear
LEA
|
+$1.16M |
| 2 |
Americold
COLD
|
+$1.09M |
| 3 |
Republic Services
RSG
|
+$1.07M |
| 4 |
Howmet Aerospace
HWM
|
+$1.07M |
| 5 |
Intercontinental Exchange
ICE
|
+$911K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$1.96M |
| 2 |
Helen of Troy
HELE
|
+$1.64M |
| 3 |
FTI Consulting
FCN
|
+$1.55M |
| 4 |
Spire
SR
|
+$1.54M |
| 5 |
McKesson
MCK
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.91% |
| 2 | Technology | 16.4% |
| 3 | Miscellaneous | 12.97% |
| 4 | Financials | 12.03% |
| 5 | Industrials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Schwab International Equity ETF
SCHF
$67.3B
| $2.25M | 1.05% |
151,202
+7,240
| +5% | +$102K |
2018 Q2
8 quarters
|
|
2
Schwab US TIPS ETF
SCHP
$16.4B
| $2.21M | 1.04% |
73,660
-1,370
| -2% | -$40.6K |
2018 Q2
8 quarters
|
|
3
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
| $2.17M | 1.02% |
89,166
+2,380
| +3% | +$54.1K |
2018 Q2
8 quarters
|
|
4
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.16B
| $1.67M | 0.78% |
54,757
+1,560
| +3% | +$47.1K |
2018 Q4
6 quarters
|
|
5
Schwab US Large- Cap ETF
SCHX
$74.2B
| $1.66M | 0.78% |
134,070
+12,720
| +10% | +$148K |
2018 Q2
8 quarters
|
|
6
Schwab US REIT ETF
SCHH
$11B
| $1.6M | 0.75% |
90,558
+5,958
| +7% | +$103K |
2018 Q2
8 quarters
|
|
7
Schwab US Mid-Cap ETF
SCHM
$14.7B
| $1.45M | 0.68% |
82,773
+9,402
| +13% | +$153K |
2018 Q2
8 quarters
|
|
8
Cadence Design Systems
CDNS
$90.8B
| $1.45M | 0.68% |
15,086
-11,214
| -43% | -$939K |
2018 Q2
8 quarters
|
|
9
Deckers Outdoor
DECK
$11B
| $1.38M | 0.64% |
42,042
-19,164
| -31% | -$528K |
2019 Q3
3 quarters
|
|
10
DELISTED
Berry Global Group, Inc.
BERY
| $1.36M | 0.64% |
33,428
-15,829
| -32% | -$594K |
2020 Q1
1 quarter
|
|
|
11
Howmet Aerospace
HWM
$76.9B
| $1.29M | 0.61% |
+81,581
| New | +$1.07M |
2020 Q2
0 quarters
|
|
12
Clorox
CLX
$10.5B
| $1.27M | 0.6% |
5,794
+972
| +20% | +$194K |
2020 Q1
1 quarter
|
|
|
13
Lear
LEA
$5.8B
| $1.27M | 0.6% |
+11,650
| New | +$1.16M |
2020 Q2
0 quarters
|
|
14
AutoZone
AZO
$51.8B
| $1.27M | 0.59% |
1,125
-520
| -32% | -$548K |
2019 Q1
5 quarters
|
|
|
DISH
15
DELISTED
DISH Network Corp.
DISH
| $1.23M | 0.57% |
35,535
+3,467
| +11% | +$96.5K |
2019 Q4
2 quarters
|
|
|
16
Americold
COLD
$4.18B
| $1.16M | 0.54% |
+31,978
| New | +$1.09M |
2020 Q2
0 quarters
|
|
17
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.15M | 0.54% |
47,325
-7,350
| -13% | -$122K |
2020 Q1
1 quarter
|
|
|
DRNA
18
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.11M | 0.52% |
43,821
-6,826
| -13% | -$147K |
2020 Q1
1 quarter
|
|
19
Acadian Asset Management
AAMI
$3.39B
| $1.11M | 0.52% |
+89,165
| New | +$730K |
2020 Q2
0 quarters
|
|
20
Everforth Inc
EFOR
$1.74B
| $1.1M | 0.51% |
+16,417
| New | +$871K |
2020 Q2
0 quarters
|
|
21
DaVita
DVA
$11.8B
| $1.09M | 0.51% |
13,809
+5,470
| +66% | +$427K |
2020 Q1
1 quarter
|
|
|
22
Republic Services
RSG
$73.8B
| $1.09M | 0.51% |
+13,326
| New | +$1.07M |
2020 Q2
0 quarters
|
|
23
Schwab Short-Term US Treasury ETF
SCHO
$15.6B
| $1.09M | 0.51% |
42,352
+14
| +0% | +$362 |
2018 Q2
8 quarters
|
|
|
FOCS
24
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.09M | 0.51% |
33,044
-5,128
| -13% | -$128K |
2019 Q4
2 quarters
|
|
25
Vertex Pharmaceuticals
VRTX
$130B
| $1.09M | 0.51% |
3,750
-565
| -13% | -$153K |
2020 Q1
1 quarter
|
|
Similar funds
RCM
RI
361 Capital's Q2 2020 Portfolio in Review
As of Q2 2020, 361 Capital held 403 positions worth $213M, down 3% from $220M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
361 Capital withdrew a net $47.5M in Q2 2020, closing 104 positions and reducing 151 holdings. Its most notable exit was Chemed, an estimated $1.96M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, 361 Capital opened a new position in Lear worth $1.27M.
- 361 Capital's largest Q2 2020 buy was Lear: 11,650 shares worth $1.27M.
- 361 Capital added most to DaVita in Q2 2020, an estimated $427K increase.
- 361 Capital's biggest Q2 2020 reduction was Williams Companies, cutting an estimated $1.41M.
- 361 Capital fully exited Chemed in Q2 2020, selling an estimated $1.96M.
- 361 Capital's ten largest holdings make up 8.1% of its $213M portfolio in Q2 2020.
- 361 Capital opened 118 new positions and closed 104 in Q2 2020.
- 361 Capital's portfolio value fell 3% quarter-over-quarter to $213M.
Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.